Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021

Abstract In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians sh...

Full description

Saved in:
Bibliographic Details
Published inOpen forum infectious diseases Vol. 10; no. 7; p. ofad342
Main Authors Gupta, Akash, Ashour, Dina, Shebl, Fatma M, Platt, Laura, Chiosi, John J, Nelson, Sandra B, Ard, Kevin L, Kim, Arthur Y, Bassett, Ingrid V
Format Journal Article
LanguageEnglish
Published US Oxford University Press 01.07.2023
Subjects
Brief Report
Online AccessGet full text

Cover

More Information
Summary:Abstract In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians should consider concurrent HCV treatment during OPAT.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Potential conflicts of interest . A. Y. K. serves on the Data Safety Monitoring Board for Kintor Pharmaceuticals, Inc. S. B. N. and K. L. A. are coauthors of the “Outpatient Parenteral Antimicrobial Therapy” article for UpToDate, Inc. All other authors report no potential conflicts.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofad342